Market Overview

Transcat Acquires Angel's Instrumentation Inc.

Share:

Acquisition expands geographic presence to Virginia and broadens
industrial on-site calibration capabilities

Transcat,
Inc.
(NASDAQ:TRNS) ("Transcat" or the "Company"), a leading
provider of accredited calibration, repair, inspection and laboratory
instrument services and value-added distributor of professional grade
handheld test, measurement and control instrumentation, announced that
it has acquired substantially all of the assets of Angel's
Instrumentation Inc. ("Angel's Instrumentation" or "AI"), effective
August 31, 2018. The purchase price was $4.7 million and is subject to
certain customary holdback provisions.

Established in 2000, AI provides in-house and on-site calibrations
nationally to the manufacturing and maritime industries from its
Chesapeake, Virginia calibration laboratory. With approximately $4
million in annual revenue, AI's comprehensive service offerings include
RF & electronic test equipment, physical, dimensional, thermal, flow and
torque calibrations. AI is accredited by the American Association of
Laboratory Accreditation ("A2LA") in accordance with the recognized
International Standard ISO/IEC 17025:2005 General requirements for the
competence of testing and calibration laboratories, and also meets the
requirements of ANSI/NCSLI Z540-1-1994 and the requirements of
ANSI/NCSLI Z540.3-2006 and R205.

"Angel's Instrumentation is a good strategic fit for us as it
strengthens our position in the mid-Atlantic region and expands our
customer base. We also plan to leverage our national footprint to lower
AI's cost of service to its national customers," commented Lee D. Rudow,
President and Chief Executive Officer of Transcat. "Importantly, Angel's
Instrumentation shares our deep commitment to quality and customer
service and we welcome the entire team to the Transcat family."

ABOUT TRANSCAT

Transcat, Inc. is a leading provider of accredited calibration, repair,
inspection and laboratory instrument services. The Company is focused on
providing best-in-class services and products to highly regulated
industries, including life science, aerospace and defense,
pharmaceutical, medical device manufacturing and biotechnology. Transcat
provides permanent and periodic on-site services, mobile calibration
services and in-house services through 21 Calibration Service Centers
strategically located across the United States, Puerto Rico and Canada.
The breadth and depth of measurement parameters addressed by Transcat's
ISO/IEC 17025 scopes of accreditation are believed to be the best in the
industry.

Transcat also operates as a leading value-added distributor that
markets, sells and rents new and used national and proprietary brand
instruments to customers primarily in North America. The Company
believes its combined Service and Distribution segment offerings,
experience, technical expertise and integrity create a unique and
compelling value proposition for its customers.

Transcat's growth strategy is to leverage the complementary nature of
its two operating segments, its comprehensive service capabilities,
strong brand, enhanced e-commerce capabilities and leading distribution
platform to drive organic sales growth. The Company will also look to
expand its addressable calibration market through acquisitions and
capability investments to further realize the inherent leverage of its
business model.

More information about Transcat can be found at: Transcat.com

Safe Harbor Statement

This news release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are not statements of historical fact and thus are subject to
risks, uncertainties and assumptions. Forward-looking statements are
identified by words such as "expects," "estimates," "projects,"
"anticipates," "believes," "could," "plans" and other similar words. All
statements addressing operating performance, events or developments that
Transcat, Inc. expects or anticipates will occur in the future,
including but not limited to statements relating to anticipated revenue,
profit margins, sales operations, capital expenditures, cash flows,
operating income, growth strategy, segment growth, potential
acquisitions, integration of acquired businesses, market position,
customer preferences, outlook and changes in market conditions in the
industries in which Transcat operates are forward-looking statements.
Forward-looking statements should be evaluated in light of important
risk factors and uncertainties. These risk factors and uncertainties are
more fully described in Transcat's Annual Report and Quarterly Reports
filed with the Securities and Exchange Commission, including under the
heading entitled "Risk Factors." Should one or more of these risks or
uncertainties materialize, or should any of the Company's underlying
assumptions prove incorrect, actual results may vary materially from
those currently anticipated. In addition, undue reliance should not be
placed on the Company's forward-looking statements. Except as required
by law, the Company disclaims any obligation to update, correct or
publicly announce any revisions to any of the forward-looking statements
contained in this news release.

View Comments and Join the Discussion!